✦ 24h Briefing Top Stories World U.S.India Business Technology Science Health Sports Entertainment

Loading

Fetching the latest headlines…

NabkaNews aggregates headlines from thousands of publishers worldwide via Google News, and provides AI-generated summaries and briefings for convenience. Every story links to its original source. We do not host or claim ownership of third-party reporting, and AI summaries may contain errors — always verify with the original source.

24h Briefing Top Stories World U.S.India Business Technology Science Health Sports Entertainment

Disclaimer Privacy Policy Terms of Use

© 2026 NabkaNews · World · U.S. · India — updated continuously. NabkaNews is an independent news aggregator and is not affiliated with any publisher shown.

Eli Lilly Stock Hits Record Highs, Becomes First Pharmaceutical Firm Worth $1 Trillion · NabkaNews

← Back to headlines

Eli Lilly Stock Hits Record Highs, Becomes First Pharmaceutical Firm Worth $1 Trillion

Yahoo Finance·May 27

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Eli Lilly's stock has reached record highs, reportedly making it the first pharmaceutical company to be valued at $1 trillion. This milestone is a notable achievement for the company. The valuation is a significant benchmark in the pharmaceutical industry.

Full coverage

Eli Lilly becomes first drugmaker to hit $1 trillion in market value

BioPharma Dive·Nov 21

Eli Lilly Stock Hits Record High as Analysts Bullish on Weight-Loss Drug Market Prospects

Eli Lilly becomes first pharma firm to join $1 trillion club

Al Jazeera·Nov 21

Lilly becomes first drugmaker to hit $1 trillion valuation on weight-loss demand

Reuters·Nov 21

Stocks Look Shaky, But This Sector is Booming (Biotech)

TradingView·6d ago

Eli Lilly Tops $1 Trillion, Joins Tech Titans In Exclusive Club

Investor's Business Daily·Nov 21

Eli Lilly Just Made History. Here's What It Means for Your Portfolio

Kavout | AI·Nov 21

Lilly Endowment Is First to Hit $100 Billion Mark on Stock Surge

Bloomberg.com·Nov 25

View original report at Yahoo Finance ↗